Larimar Therapeutics (LRMR) Free Cash Flow (2016 - 2020)
Historic Free Cash Flow for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to -$10.3 million.
- Larimar Therapeutics' Free Cash Flow fell 2880.29% to -$10.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$42.7 million, marking a year-over-year decrease of 8724.87%. This contributed to the annual value of -$71.3 million for FY2024, which is 11184.35% down from last year.
- According to the latest figures from Q4 2020, Larimar Therapeutics' Free Cash Flow is -$10.3 million, which was down 2880.29% from -$11.2 million recorded in Q3 2020.
- Over the past 5 years, Larimar Therapeutics' Free Cash Flow peaked at $3.5 million during Q2 2019, and registered a low of -$18.2 million during Q1 2016.
- Moreover, its 5-year median value for Free Cash Flow was -$11.5 million (2017), whereas its average is -$10.7 million.
- In the last 5 years, Larimar Therapeutics' Free Cash Flow surged by 12612.28% in 2019 and then tumbled by 45014.35% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Free Cash Flow stood at -$8.7 million in 2016, then fell by 13.81% to -$9.9 million in 2017, then decreased by 20.11% to -$11.8 million in 2018, then soared by 32.8% to -$8.0 million in 2019, then decreased by 28.8% to -$10.3 million in 2020.
- Its Free Cash Flow was -$10.3 million in Q4 2020, compared to -$11.2 million in Q3 2020 and -$12.2 million in Q2 2020.